Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $518.73M.
ENTERPRISE VALUE (EV)
$518.73M
Nuvectis Pharma, Inc.
Market Cap
$550.37M
Enterprise Value (EV)
$518.73M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | $550.37M | $518.73M |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $549.33M | $530.16M |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $552.54M | $480.54M |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $540.42M | $525.05M |
| Delcath Systems, Inc. (DCTH)vs › | $539.58M | $494.52M |
| ProKidney Corp. (PROK)vs › | $536.32M | $464.98M |
| CytomX Therapeutics, Inc. (CTMX)vs › | $564.94M | $553.42M |
| CorMedix Inc. (CRMD)vs › | $566.30M | $454.76M |
| Immix Biopharma, Inc. (IMMX)vs › | $528.79M | $304.30M |
Market Cap
$550.37M
Total Debt
$0.00
Cash
$31.63M
Enterprise Value
$518.73M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
